A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers.
Toledo H, Baly A, Castro O, Resik S, Laferté J, Rolo F, Navea L, Lobaina L, Cruz O, Míguez J, Serrano T, Sierra B, Pérez L, Ricardo ME, Dubed M, Lubián AL, Blanco M, Millán JC, Ortega A, Iglesias E, Pentón E, Martín Z, Pérez J, Díaz M, Duarte CA.
Toledo H, et al. Among authors: iglesias e.
Vaccine. 2001 Jul 20;19(30):4328-36. doi: 10.1016/s0264-410x(01)00111-6.
Vaccine. 2001.
PMID: 11457560
Clinical Trial.